Regulation of gene expression in osteoblasts

BioFactors

Volumn 36, Issue 1, 2010, Pages 25-32

  Jensen, Eric D ^a   Gopalakrishnan, Rajaram ^a   Westendorf, Jennifer J ^b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Atf4; HDAC; Lef1; miRs; NFATc; Osterix; Runx2; SMAD

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 4; CALCINEURIN; HISTONE DEACETYLASE; LYMPHOID ENHANCER FACTOR 1; MICRORNA; SMAD PROTEIN; T CELL FACTOR PROTEIN; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR NFAT; TRANSCRIPTION FACTOR OSTERIX; TRANSCRIPTION FACTOR RUNX2; TRANSCRIPTION FACTOR TWIST; ZINC FINGER PROTEIN;

BONE DEVELOPMENT; CELL DIFFERENTIATION; CELL FUNCTION; CELL MATURATION; CELL PROLIFERATION; EPIGENETICS; GENE EXPRESSION REGULATION; HUMAN; NONHUMAN; OSSIFICATION; OSTEOBLAST; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION;

ACTIVATING TRANSCRIPTION FACTOR 4; ANIMALS; CALCINEURIN; CORE BINDING FACTOR ALPHA 1 SUBUNIT; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HISTONE DEACETYLASES; HUMANS; LYMPHOID ENHANCER-BINDING FACTOR 1; MICE; MICRORNAS; NFATC TRANSCRIPTION FACTORS; OSTEOBLASTS; SMAD PROTEINS; T CELL TRANSCRIPTION FACTOR 1; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION FACTORS; TWIST TRANSCRIPTION FACTOR; ZINC FINGERS;

EID: 77951116026     PISSN: 09516433     EISSN: 18728081     Source Type: Journal    
DOI: 10.1002/biof.72     Document Type: Review

References (99)

1. Tapscott, S. J. (2005) The circuitry of a master switch: Myod and the regulation of skeletal muscle gene transcription. Development 132, 2685-2695.
2. Tontonoz, P. and Spiegelman B. M. (2008) Fat and beyond: the diverse biology of PPARgamma. Annu. Rev. Biochem. 77, 289-312.
3. de Crombrugghe, B., Lefebvre, V., Behringer, R. R., Bi, W., Murakami, S., and Huang, W. (2000) Transcriptional mechanisms of chondrocyte differentiation. Matrix Biol. 19, 389-394.
4. Komori, T., Yagi, H., Nomura, S., Yamaguchi, A., Sasaki, K., Deguchi, K., Shimizu, Y., Bronson, R. T., Gao, Y. H., Inada, M., Sato, M., Okamoto, R., Kitamura, Y., Yoshiki, S., and T. Kishimoto (1997) Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89, 755-764. (Pubitemid 27516178)
5. Otto, F., Thornell, A. P., Crompton, T., Denzel, A., Gilmour, K. C., Rosewell, I. R., Stamp, G. W., Beddington, R. S., Mundlos, S., Olsen, B. R., Selby, P. B., and Owen, M. J. (1997) Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 89, 765-771. (Pubitemid 27516179)
6. Shalhoub, V., Gerstenfeld, L. C., Collart, D., Lian, J. B., and Stein, G. S. (1989) Downregulation of cell growth and cell cycle regulated genes during chick osteoblast differentiation with the reciprocal expression of histone gene variants. Biochemistry 28, 5318-5322. (Pubitemid 19175738)
7. Stein, G. S., Lian, J. B., Gerstenfeld, L. G., Shalhoub, V., Aronow, M., Owen, T., and Markose, E. (1989) The onset and progression of osteoblast differentiation is functionally related to cellular proliferation. Connect. Tissue Res. 20, 3-13.
8. Stein, G. S., Lian, J. B., van Wijnen, A. J., Stein, J. L., Montecino, M., Javed, A., Zaidi, S. K., Young, D. W., Choi, J. Y., and Pockwinse, S. M. (2004) Runx2 control of organization, assembly and activity of the regulatory machinery for skeletal gene expression. Oncogene 23, 4315-4329. (Pubitemid 38758597)
9. Mundlos, S., Otto, F., Mundlos, C., Mulliken, J. B., Aylsworth, A. S., Albright, S., Lindhout, D., Cole, W. G., Henn, W., Knoll, J. H., Owen, M. J., Mertelsmann, R., Zabel, B. U., and Olsen, B. R. (1997) Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia. Cell 89, 773-779. (Pubitemid 27516180)
10. Jensen, E. D., Nair, A. K., and Westendorf, J. J. (2007) Histone deacetylase co-repressor complex control of Runx2 and bone formation. Crit. Rev. Eukaryot. Gene Expr. 17, 187-196.
11. Schroeder, T. M., Jensen, E. D., and Westendorf, J. J. (2005) Runx2: a master organizer of gene transcription in developing and maturing osteoblasts. Birth Defects Res. C Embryo Today 75, 213-225.
12. Pelletier, N., Champagne, N., Stifani, S., and Yang, X. J. (2002) MOZ and MORF histone acetyltransferases interact with the Runt-domain transcription factor Runx2. Oncogene 21, 2729-2740. (Pubitemid 34478331)
13. Sierra, J., Villagra, A., Paredes, R., Cruzat, F., Gutierrez, S., Javed, A., Arriagada, G., Olate, J., Imschenetzky, M., Van Wijnen, A. J., Lian, J. B., Stein, G. S., Stein, J. L., and Montecino, M. (2003) Regulation of the bone-specific osteocalcin gene by p300 requires Runx2/Cbfa1 and the vitamin D3 receptor but not p300 intrinsic histone acetyltransferase activity. Mol. Cell Biol. 23, 3339-3351.
14. Westendorf, J. J., Zaidi, S. K., Cascino, J. E., Kahler, R., van Wijnen, A. J., Lian, J. B., Yoshida, M., Stein, G. S., and X. Li (2002) Runx2 (Cbfa1, AML-3) interacts with histone deacetylase 6 and represses the p21(CIP1/WAF1) promoter. Mol. Cell Biol. 22, 7982-7992.
15. Jensen, E. D., Schroeder, T. M., Bailey, J., Gopalakrishnan, R., and Westendorf, J. J. (2008) Histone deacetylase 7 associates with Runx2 and represses its activity during osteoblast maturation in a deacetylation- independent manner. J. Bone Miner. Res. 23, 361-372.
16. Jeon, E. J., Lee, K. Y., Choi, N. S., Lee, M. H., Kim, H. N., Jin, Y. H., Ryoo, H. M., Choi, J. Y., Yoshida, M., Nishino, N., Oh, B. C., Lee, K. S., Lee, Y. H., and Bae, S. C. (2006) Bone morphogenetic protein-2 stimulates Runx2 acetylation. J. Biol. Chem. 281, 16502-16511.
17. Schroeder, T. M., Kahler, R. A., Li, X., and Westendorf, J. J. (2004) Histone deacetylase 3 interacts with runx2 to repress the osteocalcin promoter and regulate osteoblast differentiation. J. Biol. Chem. 279, 41998-42007.
18. Vega, R. B., Matsuda, K., Oh, J., Barbosa, A. C., Yang, X., Meadows, E., McAnally, J., Pomajzl, C., Shelton, J. M., Richardson, J. A., Karsenty, G., and Olson, E. N. (2004) Histone deacetylase 4 controls chondrocyte hypertrophy during skeletogenesis. Cell 119, 555-566. (Pubitemid 39482354)
19. Choo, M. K., Yeo, H., and Zayzafoon, M. (2009) NFATc1 mediates HDAC-dependent transcriptional repression of osteocalcin expression during osteoblast differentiation. Bone 45, 579-589.
20. Lamour, V., Detry, C., Sanchez, C., Henrotin, Y., Castronovo, V., and Bellahcene, A. (2007) Runx2- and histone deacetylase 3-mediated repression is relieved in differentiating human osteoblast cells to allow high bone sialoprotein expression. J. Biol. Chem. 282, 36240-36249.
21. Schroeder, T. M. and Westendorf, J. J. (2005) Histone deacetylase inhibitors promote osteoblast maturation. J. Bone Miner. Res. 20, 2254-2263.
22. Cho, H. H., Park, H. T., Kim, Y. J., Bae, Y. C., Suh, K. T., and Jung, J. S. (2005) Induction of osteogenic differentiation of human mesenchymal stem cells by histone deacetylase inhibitors. J. Cell. Biochem. 96, 533-542.
23. Lee, H. W., Suh, J. H., Kim, A. Y., Lee, Y. S., Park, S. Y., and Kim, J. B. (2006) Histone deacetylase 1-mediated histone modification regulates osteoblast differentiation. Mol. Endocrinol. 20, 2432-2443.
24. Tintut, Y., Parhami, F., Le, V., Karsenty, G., and Demer, L. L. (1999) Inhibition of osteoblast-specific transcription factor Cbfa1 by the cAMP pathway in osteoblastic cells. Ubiquitin/proteasome-dependent regulation. J. Biol. Chem. 274, 28875-28879.
25. Zhao, M., Qiao, M., Oyajobi, B. O., Mundy, G. R., and D. Chen (2003) E3 ubiquitin ligase Smurf1 mediates core-binding factor alpha1/Runx2 degradation and plays a specific role in osteoblast differentiation. J. Biol. Chem. 278, 27939-27944.
26. Jones, D. C., Wein, M. N., and Glimcher, L. H. (2007) Schnurri-3: a key regulator of postnatal skeletal remodeling. Adv. Exp. Med. Biol. 602, 1-13.
27. Jones, D. C., Wein, M. N., Oukka, M., Hofstaetter, J. G., Glimcher, M. J., and Glimcher, L. H. (2006) Regulation of adult bone mass by the zinc finger adapter protein Schnurri-3. Science 312, 1223-1227. (Pubitemid 43801150)
28. Glimcher, L. H., Jones, D. C., and Wein, M. N. (2007) Control of postnatal bone mass by the zinc finger adapter protein Schnurri-3. Ann. N Y Acad. Sci. 1116, 174-181.
29. Bellido, T., Ali, A. A., Plotkin, L. I., Fu, Q., Gubrij, I., Roberson, P. K., Weinstein, R. S., O'Brien, C. A., Manolagas, S. C., and Jilka, R. L. (2003) Proteasomal degradation of Runx2 shortens parathyroid hormone-induced anti-apoptotic signaling in osteoblasts. A putative explanation for why intermittent administration is needed for bone anabolism. J. Biol. Chem. 278, 50259-50272.
30. Jeong, B. C., Lee, Y. S., Park, Y. Y., Bae, I. H., Kim, D. K., Koo, S. H., Choi, H. R., Kim, S. H., Franceschi, R. T., Koh, J. T., and Choi, H. S. (2009) The orphan nuclear receptor estrogen receptor-related receptor gamma negatively regulates BMP2-induced osteoblast differentiation and bone formation. J. Biol. Chem. 284, 14211-14218.
31. Jensen, E. D., Gopalakrishnan, R., and Westendorf, J. J. (2009) Bone morphogenic protein 2 activates protein kinase D to regulate histone deacetylase 7 localization and repression of Runx2. J. Biol. Chem. 284, 2225-2234.
32. Porte, D., Tuckermann, J., Becker, M., Baumann, B., Teurich, S., Higgins, T., Owen, M. J., Schorpp-Kistner, M., and P. Angel (1999) Both AP-1 and Cbfa1-like factors are required for the induction of interstitial collagenase by parathyroid hormone. Oncogene 18, 667-678. (Pubitemid 29080324)
33. Winchester, S. K., Selvamurugan, N., D'Alonzo, R. C., and Partridge, N. C. (2000) Developmental regulation of collagenase-3 mRNA in normal, differentiating osteoblasts through the activator protein-1 and the runt domain binding sites. J. Biol. Chem. 275, 23310-23318.
34. Boumah, C. E., Lee, M., Selvamurugan, N., Shimizu, E., and Partridge, N. C. (2009) Runx2 recruits p300 to mediate parathyroid hormone's effects on histone acetylation and transcriptional activation of the matrix metalloproteinase-13 gene. Mol. Endocrinol. 23, 1255-1263.
35. Selvamurugan, N., Pulumati, M. R., Tyson, D. R., and Partridge, N. C. (2000) Parathyroid hormone regulation of the rat collagenase-3 promoter by protein kinase A-dependent transactivation of core binding factor alpha1. J. Biol. Chem. 275, 5037-5042.
36. D'Alonzo, R. C., Selvamurugan, N., Karsenty, G., and Partridge, N. C. (2002) Physical interaction of the activator protein-1 factors c-Fos and c-Jun with Cbfa1 for collagenase-3 promoter activation. J. Biol. Chem. 277, 816-822.
37. Selvamurugan, N., Jefcoat, S. C., Kwok, S., Kowalewski, R., Tamasi, J. A., and Partridge, N. C. (2006) Overexpression of Runx2 directed by the matrix metalloproteinase-13 promoter containing the AP-1 and Runx/ RD/Cbfa sites alters bone remodeling in vivo. J. Cell. Biochem. 99, 545-557.
38. Nakashima, K., Zhou, X., Kunkel, G., Zhang, Z., Deng, J. M., Behringer, R. R., and de Crombrugghe, B. (2002) The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 108, 17-29. (Pubitemid 34137009)
39. Nishio, Y., Dong, Y., Paris, M., O'Keefe, R. J., Schwarz, E. M., and Drissi, H. (2006) Runx2-mediated regulation of the zinc finger Osterix/Sp7 gene. Gene 372, 62-70.
40. Koga, T., Matsui, Y., Asagiri, M., Kodama, T., de Crombrugghe, B., Nakashima, K., and Takayanagi, H. (2005) NFAT and Osterix cooperatively regulate bone formation. Nat. Med. 11, 880-885.
41. Zhang, C., Cho, K., Huang, Y., Lyons, J. P., Zhou, X., Sinha, K., McCrea, P. D., and de Crombrugghe, B. (2008) Inhibition of Wnt signaling by the osteoblast-specific transcription factor Osterix. Proc. Natl. Acad. Sci. USA 105, 6936-6941.
42. Yang, X., Matsuda, K., Bialek, P., Jacquot, S., Masuoka, H. C., Schinke, T., Li, L., Brancorsini, S., Sassone-Corsi, P., Townes, T. M., Hanauer, A., and Karsenty, G. (2004) ATF4 is a substrate of RSK2 and an essential regulator of osteoblast biology; implication for Coffin-Lowry Syndrome. Cell 117, 387-398. (Pubitemid 38534544)
43. Yang, X. and Karsenty, G. (2004) ATF4, the osteoblast accumulation of which is determined post-translationally, can induce osteoblast-specific gene expression in non-osteoblastic cells. J. Biol. Chem. 279, 47109-47114.
44. Xiao, G., Jiang, D., Ge, C., Zhao, Z., Lai, Y., Boules, H., Phimphilai, M., Yang, X., Karsenty, G., and Franceschi, R. T. (2005) Cooperative interactions between activating transcription factor 4 and Runx2/Cbfa1 stimulate osteoblast-specific osteocalcin gene expression. J. Biol. Chem. 280, 30689-30696.
45. Yu, S., Franceschi, R. T., Luo, M., Zhang, X., Jiang, D., Lai, Y., Jiang, Y., Zhang, J., and Xiao, G. (2008) Parathyroid hormone increases activating transcription factor 4 expression and activity in osteoblasts: requirement for osteocalcin gene expression. Endocrinology 149, 1960-1968. (Pubitemid 351468354)
46. Tominaga, H., Maeda, S., Hayashi, M., Takeda, S., Akira, S., Komiya, S., Nakamura, T., Akiyama, H., and Imamura, T. (2008) CCAAT/enhancer-binding protein beta promotes osteoblast differentiation by enhancing Runx2 activity with ATF4. Mol. Biol. Cell 19, 5373-5386.
47. Yu, S., Jiang, Y., Galson, D. L., Luo, M., Lai, Y., Lu, Y., Ouyang, H. J., Zhang, J., and Xiao, G. (2008) General transcription factor IIA-gamma increases osteoblast-specific osteocalcin gene expression via activating transcription factor 4 and runt-related transcription factor 2. J. Biol. Chem. 283, 5542-5553.
48. Hinoi, E., Gao, N., Jung, D. Y., Yadav, V., Yoshizawa, T., Kajimura, D., Myers, M. G., Jr., Chua, S. C., Jr., Wang, Q., Kim, J. K., Kaestner, K. H., and Karsenty, G. (2009) An Osteoblast-dependent mechanism contributes to the leptin regulation of insulin secretion. Ann. N Y Acad. Sci. 1173 (Suppl 1), E20-E30.
49. Yoshizawa, T., Hinoi, E., Jung, D. Y., Kajimura, D., Ferron, M., Seo, J., Graff, J. M., Kim, J. K., and Karsenty, G. (2009) The transcription factor ATF4 regulates glucose metabolism in mice through its expression in osteoblasts. J. Clin. Invest. 119, 2807-2817.
50. Lee, K. S., Kim, H. J., Li, Q. L., Chi, X. Z., Ueta, C., Komori, T., Wozney, J. M., Kim, E. G., Choi, J. Y., Ryoo, H. M., and Bae, S. C. (2000) Runx2 is a common target of transforming growth factor beta1 and bone morphogenetic protein 2, and cooperation between Runx2 and Smad5 induces osteoblast-specific gene expression in the pluripotent mesenchymal precursor cell line C2C12. Mol. Cell Biol. 20, 8783-8792.
51. Bae, J. S., Gutierrez, S., Narla, R., Pratap, J., Devados, R., van Wijnen, A. J., Stein, J. L., Stein, G. S., Lian, J. B., and Javed, A. (2007) Reconstitution of Runx2/Cbfa1-null cells identifies a requirement for BMP2 signaling through a Runx2 functional domain during osteoblast differentiation. J. Cell. Biochem. 100, 434-449.
52. Hanai, J., Chen, L. F., Kanno, T., Ohtani-Fujita, N., Kim, W. Y., Guo, W. H., Imamura, T., Ishidou, Y., Fukuchi, M., Shi, M. J., Stavnezer, J., Kawabata, M., Miyazono, K., and Ito, Y. (1999) Interaction and functional cooperation of PEBP2/CBF with Smads. Synergistic induction of the immunoglobulin germline Calpha promoter. J. Biol. Chem. 274, 31577-31582.
53. Javed, A., Afzal, F., Bae, J. S., Gutierrez, S., Zaidi, K., Pratap, J., van, A. J. Wijnen, Stein, J. L., Stein, G. S., and Lian, J. B. (2009) Specific residues of RUNX2 are obligatory for formation of BMP2-induced RUNX2-SMAD complex to promote osteoblast differentiation. Cells Tissues Organs 189, 133-137.
54. Javed, A., Bae, J. S., Afzal, F., Gutierrez, S., Pratap, J., Zaidi, S. K., Lou, Y., van Wijnen, A. J., Stein, J. L., Stein, G. S., and Lian, J. B. (2008) Structural coupling of Smad and Runx2 for execution of the BMP2 osteogenic signal. J. Biol. Chem. 283, 8412-8422.
55. Afzal, F., Pratap, J., Ito, K., Ito, Y., Stein, J. L., van Wijnen, A. J., Stein, G. S., Lian, J. B., and Javed, A. (2005) Smad function and intranuclear targeting share a Runx2 motif required for osteogenic lineage induction and BMP2 responsive transcription. J. Cell Physiol. 204, 63-72. (Pubitemid 40776807)
56. Wang, Q., Wei, X., Zhu, T., Zhang, M., Shen, R., Xing, L., R.J. O'Keefe, and Chen, D. (2007) Bone morphogenetic protein 2 activates Smad6 gene transcription through bone-specific transcription factor Runx2. J. Biol. Chem. 282, 10742-10748.
57. Shen, R., Chen, M., Wang, Y. J., Kaneki, H., Xing, L., O'Keefe R. J., and Chen, D. (2006) Smad6 interacts with Runx2 and mediates Smad ubiquitin regulatory factor 1-induced Runx2 degradation. J. Biol. Chem. 281, 3569-3576.
58. Hogan, P. G., Chen, L., Nardone, J., and Rao, A. (2003) Transcriptional regulation by calcium, calcineurin, and NFAT. Genes Dev. 17, 2205-2232. (Pubitemid 37128637)
59. Bourgeois, P., Bolcato-Bellemin, A. L., Danse, J. M., Bloch-Zupan, A., Yoshiba, K., Stoetzel, C., and Perrin-Schmitt, F. (1998) The variable expressivity and incomplete penetrance of the twist-null heterozygous mouse phenotype resemble those of human Saethre-Chotzen syndrome. Hum. Mol. Genet. 7, 945-957.
60. el Ghouzzi, V., Le Merrer, M., Perrin-Schmitt, F., Lajeunie, E., Benit, P., Renier, D., Bourgeois, P., Bolcato-Bellemin, A. L., Munnich, A., and Bonaventure, J. (1997) Mutations of the TWIST gene in the Saethre-Chotzen syndrome. Nat. Genet. 15, 42-46.
61. Howard, T. D., Paznekas, W. A., Green, E. D., Chiang, L. C., Ma, N., Ortiz de Luna, R. I., Garcia Delgado, C., Gonzalez-Ramos, M., Kline, A. D., and Jabs, E. W. (1997) Mutations in TWIST, a basic helix-loop-helix transcription factor, in Saethre-Chotzen syndrome. Nat Genet 15, 36-41. (Pubitemid 27014947)
62. Bialek, P., Kern, B., Yang, X., Schrock, M., Sosic, D., Hong, N., Wu, H., Yu, K., Ornitz, D. M., Olson, E. N., Justice, M. J., and Karsenty, G. (2004) A twist code determines the onset of osteoblast differentiation. Dev. Cell 6, 423-435. (Pubitemid 38364573)
63. Hayashi, M., Nimura, K., Kashiwagi, K., Harada, T., Takaoka, K., Kato, H., Tamai, K., and Kaneda, Y. (2007) Comparative roles of Twist-1 and Id1 in transcriptional regulation by BMP signaling. J. Cell Sci. 120, 1350-1357. (Pubitemid 46780028)
64. McCabe, L. R., Banerjee, C., Kundu, R., Harrison, R. J., Dobner, P. R., Stein, J. L., Lian, J. B., and Stein, G. S. (1996) Developmental expression and activities of specific fos and jun proteins are functionally related to osteoblast maturation: role of Fra-2 and Jun D during differentiation. Endocrinology 137, 4398-4408. (Pubitemid 26321890)
65. Grigoriadis, A. E., Wang, Z. Q., Cecchini, M. G., Hofstetter, W., Felix, R., Fleisch, H. A., and Wagner, E. F. (1994) c-Fos: a key regulator of osteoclast- macrophage lineage determination and bone remodeling. Science 266, 443-448. (Pubitemid 2146943)
66. Grigoriadis, A. E., Schellander, K., Wang, Z. Q., and Wagner, E. F. (1993) Osteoblasts are target cells for transformation in c-fos transgenic mice. J. Cell Biol. 122, 685-701. (Pubitemid 23226685)
67. Jochum, W., David, J. P., Elliott, C., Wutz, A., Plenk, H., Jr., Matsuo, K., and Wagner, E. F. (2000) Increased bone formation and osteosclerosis in mice overexpressing the transcription factor Fra-1. Nat Med 6, 980-984.
68. Sabatakos, G., Sims, N. A., Chen, J., Aoki, K., Kelz, M. B., Amling, M., Bouali, Y., Mukhopadhyay, K., Ford, K., Nestler, E. J., and Baron, R. (2000) Overexpression of DeltaFosB transcription factor(s) increases bone formation and inhibits adipogenesis. Nat. Med. 6, 985-990.
69. Chang, J., Wang, Z., Tang, E., Fan, Z., McCauley, L., Franceschi, R., Guan, K., Krebsbach, P. H., and Wang, C. Y. (2009) Inhibition of osteoblastic bone formation by nuclear factor-kappaB. Nat. Med. 15, 682-689.
70. Kawamata, A., Izu, Y., Yokoyama, H., Amagasa, T., Wagner, E. F., Nakashima, K., Ezura, Y., Hayata, T., and Noda, M. (2008) JunD suppresses bone formation and contributes to low bone mass induced by estrogen depletion. J. Cell. Biochem. 103, 1037-1045.
71. Owen, T. A., Bortell, R., Yocum, S. A., Smock, S. L., Zhang, M., Abate, C., Shalhoub, V., Aronin, N., Wright, K. L., van Wijnen, A. J., et al. (1990) Coordinate occupancy of AP-1 sites in the vitamin D-responsive and CCAAT box elements by Fos-Jun in the osteocalcin gene: model for phenotype suppression of transcription. Proc. Natl. Acad. Sci. USA 87, 9990-9994.
72. Sabatakos, G., Rowe, G. C., Kveiborg, M., Wu, M., Neff, L., Chiusaroli, R., Philbrick, W. M., and Baron, R. (2008) Doubly truncated FosB isoform (Delta2DeltaFosB) induces osteosclerosis in transgenic mice and modulates expression and phosphorylation of Smads in osteoblasts independent of intrinsic AP-1 activity. J. Bone Miner. Res. 23, 584-595.
73. Behrens, J., von Kries, J. P., Kuhl, M., Bruhn, L., Wedlich, D., Grosschedl, R., and Birchmeier, W. (1996) Functional interaction of beta-catenin with the transcription factor LEF-1. Nature 382, 638-642. (Pubitemid 26268958)
74. Billin, A. N., Thirlwell, H., and Ayer, D. E. (2000) Beta-catenin-histone deacetylase interactions regulate the transition of LEF1 from a transcriptional repressor to an activator. Mol. Cell Biol. 20, 6882-6890.
75. Chen, G., Fernandez, J., Mische, S., and Courey, A. J. (1999) A functional interaction between the histone deacetylase Rpd3 and the corepressor groucho in Drosophila development. Genes Dev. 13, 2218-2230. (Pubitemid 29426727)
76. Daniels, D. L. and Weis, W. I. (2005) Beta-catenin directly displaces Groucho/TLE repressors from Tcf/Lef in Wnt-mediated transcription activation. Nat. Struct. Mol. Biol. 12, 364-371.
77. Hecht, A., Vleminckx, K., Stemmler, M. P., van Roy, F., and Kemler, R. (2000) The p300/CBP acetyltransferases function as transcriptional coactivators of beta-catenin in vertebrates. EMBO J. 19, 1839-1850. (Pubitemid 30204395)
78. Glass, D. A., II, Bialek, P., Ahn, J. D., Starbuck, M., Patel, M. S., Clevers, H., Taketo, M. M., Long, F., McMahon, A. P., Lang, R. A., and Karsenty, G. (2005) Canonical wnt signaling in differentiated osteoblasts controls osteoclast differentiation. Dev. Cell 8, 751-764. (Pubitemid 40585297)
79. Kahler, R. A. and Westendorf, J. J. (2003) Lymphoid enhancer factor-1 and beta-catenin inhibit Runx2-dependent transcriptional activation of the osteocalcin promoter. J. Biol. Chem. 278, 11937-11944.
80. Oosterwegel, M., van de Wetering, M., Timmerman, J., Kruisbeek, A., Destree, O., Meijlink, F., and Clevers, H. (1993) Differential expression of the HMG box factors TCF-1 and LEF-1 during murine embryogenesis. Development 118, 439-448. (Pubitemid 23214031)
81. van Genderen, C., Okamura, R. M., Farinas, I., Quo, R. G., Parslow, T. G., Bruhn, L., and Grosschedl, R. (1994) Development of several organs that require inductive epithelial-mesenchymal interactions is impaired in LEF-1-deficient mice. Genes Dev. 8, 2691-2703. (Pubitemid 24375419)
82. Noh, T., Gabet, Y., Cogan, J., Shi, Y., Tank, A., Sasaki, T., Criswell, B., Dixon, A., Lee, C., Tam, J., Kohler, T., Segev, E., Kockeritz, L., Woodgett, J., Muller, R., Chai, Y., Smith, E., Bab, I., and Frenkel, B. (2009) Lef1 haploinsufficient mice display a low turnover and low bone mass phenotype in a gender- and age-specific manner. PLoS One 4, e5438.
83. Kahler, R. A., Galindo, M., Lian, J., Stein, G. S., van Wijnen, A. J., and Westendorf, J. J. (2006) Lymphocyte enhancer-binding factor 1 (Lef1) inhibits terminal differentiation of osteoblasts. J. Cell. Biochem. 97, 969-983.
84. Hoeppner, L. H., Secreto, F., Jensen, E. D., Li, X., Kahler, R. A., and Westendorf, J. J. (2009) Runx2 and bone morphogenic protein 2 regulate the expression of an alternative Lef1 transcript during osteoblast maturation. J. Cell Physiol. 221, 480-489.
85. Gaur, T., Lengner, C. J., Hovhannisyan, H., Bhat, R. A., Bodine, P. V., Komm, B. S., Javed, A., van Wijnen, A. J., Stein, J. L., Stein, G. S., and Lian, J. B. (2005) Canonical WNT signaling promotes osteogenesis by directly stimulating Runx2 gene expression. J. Biol. Chem. 280, 33132-33140.
86. Bain, G., Muller, T., Wang, X., and Papkoff, J. (2003) Activated beta-catenin induces osteoblast differentiation of C3H10T1/2 cells and participates in BMP2 mediated signal transduction. Biochem. Biophys. Res. Commun. 301, 84-91.
87. Qiang, Y. W., Barlogie, B., Rudikoff, S., and Shaughnessy, J. D., Jr. (2008) Dkk1-induced inhibition of Wnt signaling in osteoblast differentiation is an underlying mechanism of bone loss in multiple myeloma. Bone 42, 669-680.
88. Rawadi, G., Vayssiere, B., Dunn, F., Baron, R., and Roman-Roman S. (2003) BMP-2 controls alkaline phosphatase expression and osteoblast mineralization by a Wnt autocrine loop. J. Bone Miner. Res. 18, 1842-1853.
89. Ambrosetti, D., Holmes, G., Mansukhani, A., and Basilico, C. (2008) Fibroblast growth factor signaling uses multiple mechanisms to inhibit Wnt-induced transcription in osteoblasts. Mol. Cell Biol. 28, 4759-4771.
90. Wu, M., Hesse, E., Morvan, F., Zhang, J. P., Correa, D., Rowe, G. C., Kiviranta, R., Neff, L., Philbrick, W. M., Horne, W. C., and Baron, R. (2009) Zfp521 antagonizes Runx2, delays osteoblast differentiation in vitro, and promotes bone formation in vivo. Bone 44, 528-536.
91. Zhang, Y., Hassan, M. Q., Xie, R. L., Hawse, J. R., Spelsberg, T. C., Montecino, M., Stein, J. L., Lian, J. B., van Wijnen, A. J., and Stein, G. S. (2009) Co-stimulation of the bone-related Runx2 P1 promoter in mesenchymal cells by SP1 and ETS transcription factors at polymorphic purine-rich DNA sequences (Y-repeats). J. Biol. Chem. 284, 3125-3135.
92. Lai, C. F., Feng, X., Nishimura, R., Teitelbaum, S. L., Avioli, L. V., Ross, F. P., and Cheng, S. L. (2000) Transforming growth factor-beta up-regulates the beta 5 integrin subunit expression via Sp1 and Smad signaling. J. Biol. Chem. 275, 36400-36406.
93. Suttamanatwong, S., Jensen, E. D., Schilling, J., Franceschi, R. T., Carlson, A. E., Mansky, K. C., and Gopalakrishnan, R. (2009) Sp proteins and Runx2 mediate regulation of matrix gla protein (MGP) expression by parathyroid hormone. J. Cell. Biochem. 107, 284-292.
94. Erson, A. E. and Petty, E. M. (2008) MicroRNAs in development and disease. Clin. Genet. 74, 296-306.
95. Li, Z., Hassan, M. Q., Volinia, S., van Wijnen, A. J., Stein, J. L., Croce, C. M., Lian, J. B., and Stein, G. S. (2008) A microRNA signature for a BMP2-induced osteoblast lineage commitment program. Proc. Natl. Acad. Sci. USA 105, 13906-13911.
96. Mizuno, Y., Yagi, K., Tokuzawa, Y., Y. Kanesaki-Yatsuka, Suda, T., Katagiri, T., Fukuda, T., Maruyama, M., Okuda, A., Amemiya, T., Kondoh, Y., Tashiro, H., and Okazaki, Y. (2008) miR-125b inhibits osteoblastic differentiation by down-regulation of cell proliferation. Biochem. Biophys. Res. Commun. 368, 267-272.
97. Itoh, T., Nozawa, Y., and Akao, Y. (2009) MicroRNA-141 and -200a are involved in bone morphogenetic protein-2-induced mouse pre-osteoblast differentiation by targeting distal-less homeobox 5. J. Biol. Chem. 284, 19272-19279.
98. Kapinas, K., Kessler, C. B., and Delany, A. M. (2009) miR-29 suppression of osteonectin in osteoblasts: regulation during differentiation and by canonical Wnt signaling. J. Cell. Biochem. 108, 216-224.
99. Mizuno, Y., Tokuzawa, Y., Ninomiya, Y., Yagi, K., Yatsuka-Kanesaki, Y., Suda, T., Fukuda, T., Katagiri, T., Kondoh, Y., Amemiya, T., Tashiro, H., and Okazaki, Y. (2009) miR-210 promotes osteoblastic differentiation through inhibition of AcvR1b. FEBS Lett. 583, 2263-2268.